Bridget T. Kiely

Bridget T. Kiely

Auto-generated profile, based on publicly available information

Bridget T. Kiely

Duke University School of Medicine Durham North Carolina USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
BKBridget T. Kiely
Bridget T. Kiely
RGRebecca Gould
Rebecca Gould
LFLeticia Flores
Leticia Flores
DBDanielle Burner
Danielle Burner
SKSamantha Kaplan
Samantha Kaplan
PKPriya Kishnani
Priya Kishnani
Purpose: Glycogen storage disease type IV (GSD IV) has historically been divided into discrete hepatic (classic hepatic, non-progressive hepatic) and neuromuscular (perinatal-congenital neuromuscular, juvenile neuromuscular) subtypes. However, the extent to which this subtype-based classification system accurately captures the landscape of phenotypic variation among GSD IV patients has not been systematically assessed.Methods: This study synthesized clinical data from all eligible cases of GSD IV in the published literature to evaluate whether this disorder is better conceptualized as discrete subtypes or a clinical continuum. A novel phenotypic scoring approach was applied to characterize the extent of hepatic, neuromuscular, and cardiac involvement in each eligible patient.Results: 146 patients met all inclusion criteria. The majority (61%) of those with sufficient data to be scored exhibited phenotypes that were not fully consistent with any of the established subtypes. These included patients who exhibited combined hepatic-neuromuscular involvement; patients whose phenotypes were intermediate between the established hepatic or neuromuscular subtypes; and patients who presented with predominantly cardiac disease.Conclusion: The application of this novel phenotypic scoring approach showed that–in contrast to the traditional subtype-based view–GSD IV may be better conceptualized as a multidimensional clinical continuum, whereby hepatic, neuromuscular, and cardiac involvement occur to varying degrees in different patients.

24 November 2022 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
LDLorna Doucette
Lorna Doucette
BKBridget T. Kiely
Bridget T. Kiely
JGJennifer M. Gierisch
Jennifer M. Gierisch
EMEve Marion
Eve Marion
LNLisa Nadler
Lisa Nadler
GUGina Upchurch
Gina Upchurch